City

Chicago (1)

Seattle (1)

Overall Status

Active, not recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

University of Chicago (1)

University of Washington (1)

Collaborator

National Cancer Institute (NCI) (1)

Novartis (1)

Intervention

bgj398 (1)

laboratory biomarker analysis (1)

pembrolizumab (1)

vorinostat (1)

Study Documents

Intervention Type

drug (2)

biological (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (2)

recurrent nasopharynx carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx

Active, not recruiting

Head and Neck Squamous Cell Carcinoma
+14 more

Laboratory Biomarker Analysis
+2 more

Seattle, Washington

Fred Hutch/University of Washington Cancer Consortium

Jan 11, 2022

FGFR Gene Amplification, FGFR1 Gene Amplification, FGFR2 Gene Amplification Trial in Chicago (BGJ398)

Terminated

FGFR Gene Amplification
+9 more

BGJ398

Chicago, Illinois

University of Chicago Comprehensive Cancer Center

Apr 9, 2019